These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26430873)

  • 1. Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.
    Abe S; Yamamoto K; Kurata M; Abe-Suzuki S; Horii R; Akiyama F; Kitagawa M
    Oncotarget; 2015 Oct; 6(33):34892-909. PubMed ID: 26430873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minichromosome maintenance 2 bound with retroviral Gp70 is localized to cytoplasm and enhances DNA-damage-induced apoptosis.
    Abe S; Kurata M; Suzuki S; Yamamoto K; Aisaki K; Kanno J; Kitagawa M
    PLoS One; 2012; 7(6):e40129. PubMed ID: 22768239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma.
    Aihemaiti G; Kurata M; Nogawa D; Yamamoto A; Mineo T; Onishi I; Kinowaki Y; Jin XH; Tatsuzawa A; Miyasaka N; Kitagawa M; Yamamoto K
    Oncotarget; 2018 Jun; 9(46):28213-28225. PubMed ID: 29963273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA damage-induced apoptosis and genetic background of the host: host-specific signaling enhancers of apoptosis.
    Kurata M; Abe S; Suzuki S; Li N; Ohnishi I; Hasegawa M; Yamamoto K; Kitagawa M
    J Med Dent Sci; 2011 Jul; 58(2):85-8. PubMed ID: 23896790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-dependent protein kinase enhances DNA damage-induced apoptosis in association with Friend gp70.
    Yamaguchi S; Hasegawa M; Aizawa S; Tanaka K; Yoshida K; Noda Y; Tatsumi K; Hirokawa K; Kitagawa M
    Leuk Res; 2005 Mar; 29(3):307-16. PubMed ID: 15661267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for acinus and MCM2 as host-specific signaling enhancers of DNA-damage-induced apoptosis in association with viral protein gp70.
    Hasegawa M; Kurata M; Yamamoto K; Yoshida K; Aizawa S; Kitagawa M
    Leuk Res; 2009 Aug; 33(8):1100-7. PubMed ID: 19058849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
    Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
    Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.
    Wang-Johanning F; Rycaj K; Plummer JB; Li M; Yin B; Frerich K; Garza JG; Shen J; Lin K; Yan P; Glynn SA; Dorsey TH; Hunt KK; Ambs S; Johanning GL
    J Natl Cancer Inst; 2012 Feb; 104(3):189-210. PubMed ID: 22247020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
    Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
    Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation.
    Yousef EM; Furrer D; Laperriere DL; Tahir MR; Mader S; Diorio C; Gaboury LA
    Mod Pathol; 2017 May; 30(5):682-697. PubMed ID: 28084344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
    Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
    Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
    Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
    Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.
    Catalano S; Panza S; Malivindi R; Giordano C; Barone I; Bossi G; Lanzino M; Sirianni R; Mauro L; Sisci D; Bonofiglio D; Andò S
    Int J Cancer; 2013 May; 132(10):2237-47. PubMed ID: 23124354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin.
    Deng M; Sun J; Xie S; Zhen H; Wang Y; Zhong A; Zhang H; Lu R; Guo L
    Mol Med Rep; 2019 Sep; 20(3):2258-2266. PubMed ID: 31322224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
    Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
    Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.